express gazette logo
The Express Gazette
Saturday, May 9, 2026

Woman says cheap pill ended her wine cravings after drinking during two pregnancies

A British woman told the Daily Mail she became sober after taking a low-cost pill she described as 'the Ozempic of alcohol', saying it stopped cravings that led her to drink while pregnant.

Health 8 months ago
Woman says cheap pill ended her wine cravings after drinking during two pregnancies

A British woman told the Daily Mail that a low-cost pill she took last year stopped her longstanding cravings for wine and left her fully sober during a second pregnancy.

The woman, 38, said she drank during her first pregnancy and had struggled for years with what she described as a middle-class dependence on wine. She said the remedy was not willpower but a pill costing £3.57 that she called "the Ozempic of alcohol," a nickname she used in recounting her experience to the newspaper.

In an account published by the Daily Mail, she recounted drinking champagne while five months pregnant on a work trip to the Maldives four years ago. She said she did not consume large quantities but that the pattern of having "a glass here and there" at social gatherings and while travelling reflected a problem with alcohol that was difficult to stop, especially wine.

Now four months into a second pregnancy and parenting a three-year-old, she said she has remained completely sober. She attributed the change to the pill she began taking last year, characterising it as "chronically under-prescribed" and saying it eliminated her longing for Chardonnay.

The woman told the Daily Mail that abstaining from other pregnancy-related restrictions, such as sushi, had been easier than giving up wine. She said the pill did not require the same kind of sustained willpower she previously relied on and that it transformed her relationship with alcohol.

The account is a personal testimony published by the Daily Mail and reflects the subject's own description of her experience. The article did not include medical records, prescribing information, or comments from clinicians about the medication the woman identified. The woman gave cost details in her account but did not provide the drug's formal name in the item published.

Experts and public health authorities caution that personal anecdotes cannot substitute for clinical evidence about the benefits or risks of medications for alcohol use. Alcohol consumption during pregnancy is widely advised against by health agencies because of potential risks to fetal development; public discussions about medications and addiction treatments generally emphasize consultation with qualified health professionals before starting or stopping any drug.

The woman's account highlights tensions between private behaviour and public health guidance: she described drinking while pregnant as a taboo few admit and said she only came forward after finding a treatment she believes worked for her. Her testimony adds to ongoing public conversations about alcohol use, addiction treatments and access to medications, but does not provide clinical verification of the pill's effectiveness beyond her personal experience.

The Daily Mail article is the source of the account; no additional outlets or independent medical commentary were included in the material provided for this report.


Sources